Tamar Hamosh Taddei MD FAASLD, AGAF
Hepatology & Liver Transplantation
Chief of GI/Hepatology, VA Connecticut Health Care System Professor of Medicine, Section of Digestive Diseases, Yale School of Medicine Director, Liver Cancer Program, VA Connecticut Health Care System
Join to View Full Profile
950 Campbell AveVeterans AdministrationWest Haven, CT 06516
Phone+1 203-932-5711
Fax+1 203-937-3873
Dr. Taddei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Gastroenterology, 2004 - 2007
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2000 - 2004
Georgetown University School of MedicineClass of 2000
Certifications & Licensure
CT State Medical License 2007 - 2026
VA State Medical License 2000 - 2022
DC State Medical License 2003 - 2004
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- The Effect of Sorafenib on Portal Pressure Start of enrollment: 2011 Aug 01
- Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis Start of enrollment: 2020 Oct 02
Publications & Presentations
PubMed
- 1 citationsValidation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death.Philip Vutien, Abbey Barnard Giustini, Nicole J Kim, Andrew M Moon, Chun-Nan Hsu
Hepatology. 2025-08-01 - 3 citationsValidation and Epidemiologic Definition of the Novel Steatotic Liver Disease Nomenclature in a National United States Cohort With Cirrhosis.Catherine Mezzacappa, Pedro Ochoa-Allemant, Marina Serper, Tamar H Taddei, Binu V John
Clinical Gastroenterology and Hepatology. 2025-08-01 - Prognostic significance of mild ascites in patients with cirrhosis.Nicolas Chong Lugon, Anahita Rabiee, Catherine Mezzacappa, David E Kaplan, Tamar H Taddei
Hepatology. 2025-07-03
Press Mentions
American Liver Foundation and the United States Department of Veterans Affairs and Veteran Health Administration Partner to Help Veterans at Risk or Living with Liver DiseaseJanuary 23rd, 2025- Listen to "Liver Cancer Screening: A New Tool for Improved-DetectionNovember 8th, 2024
- Liver Cancer Screening Post-Hep C Cure Improves SurvivalSeptember 10th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
